Effects of mastic gum Pistacia lentiscus van Chia on innate cellular immune effectors

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 2, 2009, Pages 143-149

  Kottakis, Filippos ^a   Kouzi Koliakou, Kokona ^b   Pendas, Stefanos ^a,c   Kountouras, Jannis ^c   Choli Papadopoulou, Theodora ^a  

^a School of Chemistry   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Arabinogalactan proteins; Chios mastic gum; Helicobacter pylori; Helicobacter pylori neutrophil activating protein; Neutrophils

Indexed keywords

ARABINOGALACTAN; CHIOS MASTIC GUM; CYTOCHROME C; IMMUNOMODULATING AGENT; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PISTACIA LENTISCUS AGENT; PLANT EXTRACT; UNCLASSIFIED DRUG; ARABINOGALACTAN PROTEINS; BACTERIAL PROTEIN; GUM MASTIC; IMMUNOLOGIC FACTOR; MEMBRANE PROTEIN; MUCOPROTEIN; NEUTROPHIL-ACTIVATING PROTEIN A, HELICOBACTER PYLORI; PLANT RESIN; VEGETABLE PROTEIN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; DRUG BINDING; DRUG EFFECT; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MALE; MICROSCOPY; NONHUMAN; PISTACIA LENTISCUS; PRIORITY JOURNAL; VARIETAS; CELL CULTURE; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; HELICOBACTER INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEUTROPHIL; PISTACIA; YOUNG ADULT;

ADULT; AGED; BACTERIAL PROTEINS; CELLS, CULTURED; FEMALE; HELICOBACTER INFECTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUCOPROTEINS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PISTACIA; PLANT PROTEINS; RESINS, PLANT; YOUNG ADULT;

EID: 59149097584     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32831c50c9     Document Type: Article

References (37)

1. Magiatis P, Melliou E, Skaltsounis AL, Chinou IB, Mitaku S. Chemical composition and antimicrobial activity of the essential oils of pistacia lentiscus var. Chia Plan (a Med 1999; 65:749-752.
2. Papageorgiou V, Mellidis A, Argyriadou N. The chemical composition of the essential oil of mastic gum. J Ess Oil Res 1991; 3:107-111.
3. lauk L, Ragusa S, Rapisarda A, Franco S, Nicolosi VM. In vitro antimicrobial activity of pistacia lentiscus I. extracts: preliminary report. J Chemother 1996; 8:207-209.
4. Koutsoudaki C, Krsek M, Rodger A. Chemical composition and antibacterial activity of the essential oil and the gum of pistacia lentiscus var. Chia. J Agric Food Chem 2005; 53:7681-7685.
5. Takahashi K, Fukazawa M, Motohira H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. J Periodontol 2003; 74:501-505.
6. Aksoy A, Duran N, Koksal F. In vitro and in vivo antimicrobial effects of mastic chewing gum against streptococcus mutans and mutans streptococci. Arch Oral Biol 2006; 51:476-481.
7. Al-Habbal MJ, Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol 1984; 11:541-544.
8. Al-Said MS, Ageel AM, Parmar NS, Tariq M. Evaluation of mastic, a crude drug obtained from pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol 1986; 15:271-278.
9. Huwez FU, Thirlwell D, Cockayne A, Ala'Aldeen DA. Mastic gum kills helicobacter pylori. N Engl J Med 1998; 339:1946.
10. Marone P, Bono L, Leone E, Bona S, Carretto E, Perversi L. Bactericidal activity of pistacia lentiscus mastic gum against helicobacter pylori. J Chemother 2001; 13:611-614.
11. Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, et al. In vitro and in vivo activities of chios mastic gum extracts and constituents against helicobacter pylori. Antimicrob Agents Chemother 2007; 51:551-559.
12. Bebb JR, Bailey-Flitter N, Ala'Aldeen D, Atherton JC. Mastic gum has no effect on helicobacter pylori load in vivo. J Antimicrob Chemother 2003; 52:522-523.
13. Loughlin MF, Ala'Aldeen DA, Jenks PJ. Monotherapy with mastic does not eradicate helicobacter pylori infection from mice. J Antimicrob Chemother 2003; 51:367-371.
14. Kottakis F, Lamari F, Matragkou C, Zachariadis G, Karamanos N, Choli-Papadopoulou T. Arabino-galactan proteins from pistacia lentiscus var. Chia: isolation, characterization and biological function. Amino Acids 2008; 34:413-420. doi 10.1007/s00726-007-0554-8.
15. Classen B, Witthohn K, Blaschek W. Characterization of an arabinogalactan-protein isolated from pressed juice of echinacea purpurea by precipitation with the beta-glucosyl yariv reagent Carbohydr Res 2000; 327:497-504.
16. Wagner H, Stuppner H, Schafer W, Zenk M. Immunologically active polysaccharides of echinacea purpurea cell cultures. Phytochemistry 1988; 27:119-126.
17. Alban S, Classen B, Brunner G, Blaschek W. Differentiation between the complement modulating effects of an arabinogalactan-protein from echinacea purpurea and heparin. Planta Med 2002; 68:1118-1124.
18. Diallo D, Paulsen BS, Liljeback TH, Michaelsen TE. Polysaccharides from the roots of entada africana guill. Et perr., mimosaceae, with complement fixing activity. J Ethnopharmacol 2001; 74:159-171.
19. Thude S, Classen B, Blaschek W, Barz D, Thude H. Binding studies of an arabinogalactan-protein from echinacea purpurea to leucocytes. Phytomedicine 2006; 13:425-427.
20. Classen B, Mau SL, Bacic A. The arabinogalactan-proteins from pressed juice of echinacea purpurea belong to the hybrid class of hydroxyproline-rich glycoproteins. Planta Med 2005; 71:59-66.
21. Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG, Venizelos J. Eradication of helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma Arch Intern Med 2002; 162:1237-1244.
22. Fredlund H, Olcen P, Danielsson D. A reference procedure to study chemiluminescence induced in polymorphonuclear leukocytes by neisseria meningitidis. Apmis 1988; 96:941-949.
23. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory; 1988.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 1970; 227:680-685.
25. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tiss Ant 1974; 4:269-274.
26. Lal AS, Parker RJ, Segal AW. Characterization and partial purification of a novel neutrophil membrane-associated kinase capable of phosphorylating the respiratory burst component p47 phox. Biochem J 1999; 338 (Pt 2):359-366.
27. Rothfus JA, Smith EL. Glycopeptides. Iv. The periodate oxidation of glycopeptides from human gamma-globulin. J Biol Chem 1963; 238:1402-1410.
28. Spector DL, Goldman RD, Leinwand LA. Cells: a laboratory manual. Plainview, NY: Cold Spring Harbor Laboratory Press; 1998.
29. Nishioka H, Baesso I, Semenzato G, Trentin L, Rappuoli R, Del Giudice G, Montecucco C. The neutrophil-activating protein of helicobacter pylori (hp-nap) activates the mapk pathway in human neutrophils. Eur J Immunol 2003; 33:840-849.
30. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterol 2001; 48:743-751.
31. Teneberg S, Jurstrand M, Karlsson KA, Danielsson D. Inhibition of nonopsonic helicobacter pylori-induced activation of human neutrophils by sialylated oligosaccharides. Glycobiology 2000; 10:1171-1181.
32. Miller-Podraza H, Bergstrom J, Teneberg S, Milh MA, Longard M, Olsson BM, et al. Helicobacter pylori and neutrophils: Sialic acid-dependent binding to various isolated glycoconjugates. Infect Immun 1999; 67:6309-6313.
33. Teneberg S, Miller-Podraza H, Lampert HC, Evans DJ Jr, Evans DG, Danielsson D, Karlsson KA. Carbohydrate binding specificity of the neutrophil-activating protein of helicobacter pylori. J Biol Chem 1997; 272:19067-19071.
34. Balan KV, Prince J, Han Z, Dimas K, Cladaras M, Wyche JH, et al. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from pistacia lentiscus I. Var. Chia. Phytomedicine 2007; 14:263-272.
35. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005; 40: 887-893.
36. Kountouras J, Toumounis L, Karatzoglou P, Zavos C, Chatzopoulos D, Venizelos I, Lazaraki G. In situ h. Pylori infection and oncogenes'expression in patients with colorectal cancer. Gut 2004; 53:A270.
37. He ML, Li A, Xu CS, Wang SL, Zhang MJ, Gu H, et al. Mechanisms of antiprostate cancer by gum mastic: Nf-kappab signal as target. Acta Pharmacol Sin 2007; 28:446-452.